Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Biol Chem ; 285(36): 28141-55, 2010 Sep 03.
Artículo en Inglés | MEDLINE | ID: mdl-20551313

RESUMEN

The lumican gene (lum), which encodes one of the major keratan sulfate proteoglycans (KSPGs) in the vertebrate cornea and sclera, has been linked to axial myopia in humans. In this study, we chose zebrafish (Danio rerio) as an animal model to elucidate the role of lumican in the development of axial myopia. The zebrafish lumican gene (zlum) spans approximately 4.6 kb of the zebrafish genome. Like human (hLUM) and mouse (mlum), zlum consists of three exons, two introns, and a TATA box-less promoter at the 5'-flanking region of the transcription initiation site. Sequence analysis of the cDNA predicts that zLum encodes 344 amino acids. zLum shares 51% amino acid sequence identity with human lumican. Similar to hLUM and mlum, zlum mRNA is expressed in the eye and many other tissues, such as brain, muscle, and liver as well. Transgenic zebrafish harboring an enhanced GFP reporter gene construct downstream of a 1.7-kb zlum 5'-flanking region displayed enhanced GFP expression in the cornea and sclera, as well as throughout the body. Down-regulation of zlum expression by antisense zlum morpholinos manifested ocular enlargement resembling axial myopia due to disruption of the collagen fibril arrangement in the sclera and resulted in scleral thinning. Administration of muscarinic receptor antagonists, e.g. atropine and pirenzepine, effectively subdued the ocular enlargement caused by morpholinos in in vivo zebrafish larvae assays. The observation suggests that zebrafish can be used as an in vivo model for screening compounds in treating myopia.


Asunto(s)
Proteoglicanos Tipo Condroitín Sulfato/deficiencia , Proteoglicanos Tipo Condroitín Sulfato/genética , Técnicas de Silenciamiento del Gen , Sulfato de Queratano/deficiencia , Sulfato de Queratano/genética , Esclerótica/anatomía & histología , Esclerótica/metabolismo , Pez Cebra/genética , Secuencia de Aminoácidos , Animales , Animales Modificados Genéticamente , Bovinos , Proteoglicanos Tipo Condroitín Sulfato/química , Proteoglicanos Tipo Condroitín Sulfato/metabolismo , Colágeno/metabolismo , Secuencia Conservada , Sustancia Propia/metabolismo , Evaluación Preclínica de Medicamentos , Regulación de la Expresión Génica , Humanos , Sulfato de Queratano/química , Sulfato de Queratano/metabolismo , Larva/anatomía & histología , Larva/efectos de los fármacos , Lumican , Ratones , Datos de Secuencia Molecular , Antagonistas Muscarínicos/farmacología , Miopía/tratamiento farmacológico , Tamaño de los Órganos/efectos de los fármacos , Tamaño de los Órganos/genética , Filogenia , Regiones Promotoras Genéticas/genética , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Esclerótica/patología , Esclerótica/ultraestructura , Alineación de Secuencia , Pez Cebra/embriología
2.
J Gene Med ; 9(11): 956-66, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17724775

RESUMEN

BACKGROUND: This study evaluates the eye drop delivery of genes with cornea-specific promoters, i.e., keratin 12 (K12) and keratocan (Kera3.2) promoters, by non-ionic poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) polymeric micelles (PM) to mouse and rabbit eyes, and investigates the underlying mechanisms. METHODS: Three PM-formulated plasmids (pCMV-Lac Z, pK12-Lac Z and pKera3.2-Lac Z) containing the Lac Z gene for beta-galactosidase (beta-Gal) whose expression was driven by the promoter of either the cytomegalovirus early gene, the keratin 12 gene or the keratocan gene, were characterized by critical micelle concentration (CMC), dynamic light scattering (DLS), and atomic force microscopy (AFM). Transgene expression in ocular tissue after gene delivery was analyzed by 5-bromo-4-chloro-3-indolyl-beta-D-galactoside (X-Gal) color staining, 1,2-dioxetane beta-Gal enzymatic activity measurement, and real-time polymerase chain reaction (PCR) analysis. The delivery mechanisms of plasmid-PM on mouse and rabbit corneas were evaluated by EDTA and RGD (arginine-glycine-aspartic acid) peptide. RESULTS: The sizes of the three plasmid-PM complexes were around 150-200 nm with unimodal distribution. Enhanced stability was found for three plasmid-PM formulations after DNase I treatment. After six doses of eye drop delivery of pK12-Lac Z-PM three times a day, beta-Gal activity was significantly increased in both mouse and rabbit corneas. Stroma-specific Lac Z expression was only found in pKera3.2-Lac Z-PM-treated animals with pretreatment by 5 mM EDTA, an opener of junctions. Lac Z gene expression in both pK12-Lac Z-PM and pKera3.2-Lac Z-PM delivery groups was decreased by RGD peptide pretreatment. CONCLUSIONS: Cornea epithelium- and stroma-specific gene expression could be achieved using cornea-specific promoters of keratin 12 and keratocan genes, and the gene was delivered with PM formulation through non-invasive, eye drop in mice and rabbits. The transfection mechanism of plasmid-PM may involve endocytosis and particle size dependent paracellular transport.


Asunto(s)
Córnea/metabolismo , Sistemas de Liberación de Medicamentos/métodos , Micelas , Nanopartículas/uso terapéutico , Soluciones Oftálmicas/química , Animales , Enfermedades de la Córnea/terapia , Expresión Génica , Vectores Genéticos , Queratina-12/administración & dosificación , Queratina-12/genética , Ratones , Nanopartículas/química , Polietilenglicoles/uso terapéutico , Regiones Promotoras Genéticas , Glicoles de Propileno/uso terapéutico , Proteoglicanos/administración & dosificación , Proteoglicanos/genética , Conejos , Transgenes
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA